Treating clonorchiasis with three different drugs
Treatments studied
Part of Infections clinical trials.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with clonorchiasis (a liver fluke infection) through a stool or bile test.
- You are not allergic to albendazole, praziquantel, or tribendimidine.
- You do not have certain heart rhythm problems (supraventricular tachycardia or atrial fibrillation).
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use effective birth control during the study and for 3 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.
This study compares two different medicines (oxfendazole and triclabendazole) to treat chronic fascioliasis, a parasitic liver infection. It aims to find the most effective and safe treatment option.
This study tests whether giving two medicines (praziquantel and albendazole) together works better than just one medicine (albendazole) to kill the parasite that causes neurocysticercosis. If you have this brain infection and have had seizures, you might be able to participate.
This trial tests whether giving treatment for schistosomiasis (a parasite infection) more often helps reduce liver scarring (fibrosis). It compares different schedules of medication to see which works best and may improve liver health.
This trial is testing the drug albendazole in people who have Loa loa, a worm infection that can cause itchy swellings. The study will see if a 21-day course of albendazole helps clear the infection better than a placebo.
Hear when a new Clonorchiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.